{"id":"e9cc93fe-41bb-4766-a495-246f57c610d2","slug":"eduardo-fonseca","name":"Eduardo Fonseca","bioBrief":"CEO of EndoQuest Robotics. Leading PARADIGM Trial through FDA final stage. Partnered with NVIDIA IGX Thor. Series D-2 co-led by Crescent Enterprises and Dr. Fred Moll.","priorExits":null,"nationality":null,"verificationPosture":"reported","aliases":[],"sources":[{"url":"https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/","title":"EndoQuest FDA Green Light","sourceName":"MassDevice","dateAccessed":"2026-07-22"}],"reviewStatus":"unreviewed","createdAt":"2026-07-23T02:09:46.387Z","updatedAt":"2026-07-23T02:09:46.387Z","educations":[],"companyRoles":[{"id":"04030354-705e-4351-93f9-9271cfde5bac","personId":"e9cc93fe-41bb-4766-a495-246f57c610d2","companyId":"06e82f4d-e2d5-4a09-a089-c752f2f22056","role":"ceo","roleTitle":"CEO","startDate":null,"endDate":null,"currentRole":true,"roleBasis":"reported_not_verified","createdAt":"2026-07-23T02:09:46.778Z","company":{"slug":"endoquest","name":"EndoQuest Robotics"}}],"boardRoles":[],"investorRoles":[],"foundings":[]}